MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202531092802 A) filed by National Institute Of Pharmaceutical Education And Research, Hajipur, Bihar, on Sept. 26, 2025, for 'synthesis of panduratin analogs and related methods.'
Inventor(s) include Jana, Anupam; Hussain, Mohammad Zahid; and Ramalingam, P.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "The synthesis of Panduratin analogs involves a Diels-Alder reaction pathway, utilizing chalcone intermediates and alkenyl compounds under controlled thermal and pressure conditions. The process includes purification through column chromatography with an ethyl acetate-hexane solvent system and structural verification by matching NMR and MS data to natural standards. The synthesized analogs demonstrate potential biological activities, such as anticancer, antimicrobial, and antiviral effects, as indicated by preliminary bioassays."
Disclaimer: Curated by HT Syndication.
